Mechanisms for modulation of mouse gastrointestinal motility by proteinase-activated receptor (PAR)-1 and-2 in vitro

被引:19
|
作者
Sekiguchi, F
Hasegawa, N
Inoshita, K
Yonezawa, D
Inoi, N
Kanke, T
Saito, N
Kawabata, A
机构
[1] Kinki Univ, Sch Pharmaceut Sci, Div Physiol & Pathophysiol, Higashiosaka, Osaka 5778502, Japan
[2] Kowa Co Ltd, Div Pharmaceut, Tokyo New Drug Res Lab 2, Tokyo 1890022, Japan
基金
日本学术振兴会;
关键词
protemase (protease)-activated receptor (PAR); stomach; intestine; gastrointestinal smooth muscle; contraction; relaxation; apamin; indomethacin; capsaicin; PAR-2-knockout mouse;
D O I
10.1016/j.lfs.2005.06.035
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Proteinase-activated receptor (PAR)-1 or -2 modulates gastrointestinal transit in vivo. To clarify the underlying mechanisms, we characterized contraction/relaxation caused by TFLLR-NH2 and SLIGRL-NH2, PAR-1- and -2-activating peptides, respectively, in gastric and small intestinal (duodenal, jejunal and ileal) smooth muscle isolated from wild-type and PAR-2-knockout mice. Either SLIGRL-NH2 or TFLLR-NH2 caused both relaxation and contraction in the gastrointestinal preparations from wild-type animals. Apamin, a K+ channel inhibitor, tended to enhance the peptide-evoked contraction in some of the gastrointestinal preparations, whereas it inhibited relaxation responses to either peptide completely in the stomach, but only partially in the small intestine. Indomethacin reduced the contraction caused by SLIGRL-NH2 or TFLLR-NH2 in both gastric and ileal preparations, but unaffected apamin-insensitive relaxant effect of either peptide in ileal preparations. Repeated treatment with capsaicin suppressed the contractile effect of either peptide in the stomach, but not clearly in the ileum, whereas it enhanced the apamin-insensitive relaxant effect in ileal preparations. In any gastrointestinal preparations from PAR-2-knockout mice, SLIGRL-NH2, produced no responses. Thus, the inhibitory component in tension modulation by PAR-1 and -2 involves both apamin-sensitive and -insensitive mechanisms in the small intestine, but is predominantly attributable to the former mechanism in the stomach. The excitatory component in the PAR-1 and -2 modulation may be mediated, in part, by activation of capsaicin-sensitive sensory nerves and/or endogenous prostaglandin formation. Our study thus clarifies the multiple mechanisms for gastrointestinal motility modulation by PAR-1 and -2, and also provides ultimate evidence for involvement of PAR-2. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:950 / 957
页数:8
相关论文
共 50 条
  • [1] Mechanisms for modulation of mouse gastrointestinal motility caused by protease-activated receptor (PAR)-1 and PAR-2 activation
    Sekiguchi, F
    Hasegawa, N
    Yonezawa, D
    Inoi, N
    Kanke, T
    Saito, N
    Kawabata, A
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 257P - 257P
  • [2] Modified proteinase-activated receptor-1 and-2 derived peptides inhibit proteinase-activated receptor-2 activation by trypsin
    Al-Ani, B
    Saifeddine, M
    Wijesuriya, SJ
    Hollenberg, MD
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (02): : 702 - 708
  • [3] Mechanisms underlying impaired desensitization of proteinase-activated receptor 1 (PAR1)
    Hirano, Katsuya
    Hirano, Mayumi
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 160P - 160P
  • [4] Novel mechanisms of desensitization and resensitization of proteinase-activated receptor 2 (PAR-2)
    Bohm, SK
    Khitin, L
    Grady, EF
    Camp, PD
    Lovett, M
    Payan, DG
    Bunnett, NW
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A1060 - A1060
  • [5] Novel Role for Proteinase-activated Receptor 2 (PAR2) in Membrane Trafficking of Proteinase-activated Receptor 4 (PAR4)
    Cunningham, Margaret R.
    McIntosh, Kathryn A.
    Pediani, John D.
    Robben, Joris
    Cooke, Alexandra E.
    Nilsson, Mary
    Gould, Gwyn W.
    Mundell, Stuart
    Milligan, Graeme
    Plevin, Robin
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (20) : 16656 - 16669
  • [6] Proteinase-activated receptor 2 (PAR-2) in gastrointestinal and pancreatic pathophysiology, inflammation and neoplasia
    Soreide, Kjetil
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2008, 43 (08) : 902 - 909
  • [7] Proteinase-activated receptor 1 (PAR-1) and cell apoptosis
    Flynn, AN
    Buret, AG
    [J]. APOPTOSIS, 2004, 9 (06) : 729 - 737
  • [8] Proteinase-activated receptor 1 (PAR-1) and cell apoptosis
    A. N. Flynn
    A. G. Buret
    [J]. Apoptosis, 2004, 9 : 729 - 737
  • [9] Proteinase-activated receptor (PAR)-1 and-2 agonists induce mediator release from mast cells by pathways distinct from PAR-1 and PAR-2
    Stenton, GR
    Nohara, O
    Dery, RE
    Vliagoftis, H
    Gilchrist, M
    Johri, A
    Wallace, JL
    Hollenberg, MD
    Moqbel, R
    Befus, AD
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (02): : 466 - 474
  • [10] Basic and Translational Research on Proteinase-Activated Receptors: Implication of Proteinase/Proteinase-Activated Receptor in Gastrointestinal Inflammation
    Yoshida, Norimasa
    Yoshikawa, Toshikazu
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 108 (04) : 415 - 421